Prostate motion in magnetic resonance imaging-guided radiotherapy and its impact on margins
Open Access
- 14 January 2025
- journal article
- research article
- Published by Springer Nature in Strahlentherapie und Onkologie
- Vol. 201 (8) , 799-806
Abstract
Purpose: This study focused on reducing the margin for prostate cancer treatment using magnetic resonance imaging-guided radiotherapy by investigating the intrafractional motion of the prostate and different motion-mitigation strategies. Methods: We retrospectively analyzed intrafractional prostate motion in 77 patients with low- to intermediate-risk prostate cancer treated with five fractions of 7.25 Gy on a 1.5 T magnetic resonance linear accelerator. Systematic drift motion was observed and described by an intrafractional motion model. The planning target volume (PTV) margin was calculated in a cohort of 77 patients and prospectively evaluated for geometric coverage in a separate cohort of 24 patients. Results: The intrafractional model showed that the prostate position starts out of equilibrium for the anterior–posterior (−1.8 ± 3.1 mm) and superior–inferior (1.7 ± 2.6 mm) directions, with relaxation times of 12 and 15 min, respectively. Position verification scans are acquired at 30 min on average. At that time, the transient drift motion becomes indistinguishable from the residual random intrafractional motion. PTV margins can be reduced to 1.8 mm (left–right), 3.2 mm (anterior–posterior), and 2.9 mm (superior–inferior). Evaluation of the overlap with the clinical target volume (CTV) was performed for a total of 120 fractions of 24 patients. The overlap range between the CTV and the PTV was 93–100% and the applied 3‑mm PTV margin for the CTV had a 99.5% averaged geometric overlap for all patients. Conclusion: A PTV margin reduction to 3 mm is feasible. A patient-specific approach could reduce the margins further.Keywords
This publication has 30 references indexed in Scilit:
- Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trialThe Lancet Oncology, 2019
- Adaptive radiotherapy: The Elekta Unity MR-linac conceptClinical and Translational Radiation Oncology, 2019
- MRI-guided prostate adaptive radiotherapy – A systematic reviewRadiotherapy and Oncology, 2016
- Intra-fraction motion of the prostate is a random walkPhysics in Medicine & Biology, 2014
- The ViewRay System: Magnetic Resonance–Guided and Controlled RadiotherapySeminars in Radiation Oncology, 2014
- The random walk model of intrafraction movementPhysics in Medicine & Biology, 2013
- Integrating a 1.5 T MRI scanner with a 6 MV accelerator: proof of conceptPhysics in Medicine & Biology, 2009
- Intrafraction Motion of the Prostate During External-Beam Radiation Therapy: Analysis of 427 Patients with Implanted Fiducial MarkersInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007
- Errors and margins in radiotherapySeminars in Radiation Oncology, 2004
- The probability of correct target dosage: dose-population histograms for deriving treatment margins in radiotherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2000